Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs ...

CAMBRIDGE, England & STEVENAGE, England--(BUSINESS WIRE)--Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and ...

To start off, could you introduce yourselves and Unicorn Biotechnologies? Jack: I’m Jack, one of the co-founders of Unicorn Biotechnologies. My background is in chemistry, and I’ve worked across ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced their xCELLigence RTCA HT (real-time cell analysis high-throughput) platform now integrates with the BioTek ...

KARLSKOGA, Sweden, Nov. 7, 2025 /PRNewswire/ -- Cell Impact and thyssenkrupp Automation Engineering have entered a Strategic Cooperation Agreement for Joint Market Success in the Field of Hydrogen.

Automation will help the cell therapy sector reduce the number of expert staff needed to manufacture these lifesaving therapies, thereby making them more affordable. A team, led by researchers at the ...

Multiply Labs, a San Francisco-based robotics company developing advanced automated manufacturing systems for cell therapies, announced an expansion of its collaboration with Thermo Fisher Scientific.

MONTREAL, May 5, 2025 /PRNewswire/ - Vention, creator of the world's only full-stack software and hardware automation platform, today announced the commercial availability of its powerful ...

FRANKLIN LAKES, N.J., Oct. 8, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for ...

Alithea Genomics has gained recognition for transforming RNA sequencing with its scalable and cost-effective solutions. MERCURIUS FLASH-seq, a novel single-cell RNA-seq protocol, offers gene detection ...